1) gastrointestinal retentiveness
胃肠道滞留
2) gastric retentive oral dosage
胃滞留剂
1.
Advances of gastric retentive oral dosage for the treatment of peptic ulcer;
治疗消化性溃疡胃滞留剂的研究进展
3) gastric residential tablets
胃滞留片
1.
:OBJECTIVE To make amoxicillin gastric residential tablets by using carbopol and hydroxypro pylmethylcellose(HPMC).
目的:以卡波姆、羟丙甲基纤维素等辅料制备阿莫西林胃滞留片。
4) gastroretentive
胃滞留
1.
Preparation and in vitro evaluation of gastroretentive dosage form containing puerarin-HP-β-CD inclusion complex;
含葛根素-羟丙基-β-环糊精包合物胃滞留制剂的制备与体外评价
5) gastroretentive dosage forms
胃内滞留
1.
Expandable gastroretentive dosage forms do not easily pass through the pyloric sphincter in the stomach due to the expandable properties that prolong their gastric retention time(GRT).
胃内膨胀型制剂属于胃内滞留制剂的一种,此类制剂符合缓控释制剂的要求,增加药物在胃部的吸收,提高生物利用度。
6) gastric stagnation tablets
胃内滞留片
1.
Ornidazole gastric stagnation tablets was prepared by using HPMC and octadecanol.
以羟丙基甲基纤维素(HPMC)为亲水性骨架材料,十八醇为助漂剂,采用融熔法制备出起漂、持漂且释放度均满足要求的奥硝唑胃内滞留片,并建立了其质量标准。
补充资料:胃肠道
胃肠道
胃和肠道的总称。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条